<VariationArchive RecordType="classified" VariationID="988943" VariationName="GRCh37/hg19 Xp22.33-22.32(chrX:60000-4857212)x1" VariationType="copy number loss" Accession="VCV000988943" Version="4" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-04-09" DateCreated="2020-12-19" MostRecentSubmission="2023-03-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="976870" VariationID="988943">
      <GeneList>
        <Gene Symbol="XG" FullName="Xg glycoprotein (Xg blood group)" GeneID="7499" HGNC_ID="HGNC:12806" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xp22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="2752040" stop="2816500" display_start="2752040" display_stop="2816500" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="2670092" stop="2734540" display_start="2670092" display_stop="2734540" Strand="+" />
          </Location>
          <OMIM>300879</OMIM>
        </Gene>
        <Gene Symbol="ARSD" FullName="arylsulfatase D" GeneID="414" HGNC_ID="HGNC:717" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xp22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="2903972" stop="2929339" display_start="2903972" display_stop="2929339" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="2822010" stop="2847415" display_start="2822010" display_stop="2847415" Strand="-" />
          </Location>
          <OMIM>300002</OMIM>
          <Haploinsufficiency last_evaluated="2016-07-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ARSD">No evidence available</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2016-07-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ARSD">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="ARSD-AS1" FullName="ARSD antisense RNA 1" GeneID="100506356" HGNC_ID="HGNC:40085" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xp22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="2904904" stop="2906122" display_start="2904904" display_stop="2906122" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="2822945" stop="2824188" display_start="2822945" display_stop="2824188" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="ARSF" FullName="arylsulfatase F" GeneID="416" HGNC_ID="HGNC:721" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xp22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="3040234" stop="3112727" display_start="3040234" display_stop="3112727" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="2958274" stop="3030769" display_start="2958274" display_stop="3030769" Strand="+" />
          </Location>
          <OMIM>300003</OMIM>
        </Gene>
        <Gene Symbol="ARSH" FullName="arylsulfatase family member H" GeneID="347527" HGNC_ID="HGNC:32488" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xp22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="3006546" stop="3034111" display_start="3006546" display_stop="3034111" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="2924653" stop="2951425" display_start="2924653" display_stop="2951425" Strand="+" />
          </Location>
          <OMIM>300586</OMIM>
        </Gene>
        <Gene Symbol="ARSL" FullName="arylsulfatase L" GeneID="415" HGNC_ID="HGNC:719" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xp22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="2934521" stop="2968245" display_start="2934521" display_stop="2968245" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="2852672" stop="2882493" display_start="2852672" display_stop="2882493" Strand="-" />
          </Location>
          <OMIM>300180</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ARSE">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ARSE">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="GYG2" FullName="glycogenin 2" GeneID="8908" HGNC_ID="HGNC:4700" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xp22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="2828930" stop="2882818" display_start="2828930" display_stop="2882818" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="2746862" stop="2800860" display_start="2746862" display_stop="2800860" Strand="+" />
          </Location>
          <OMIM>300198</OMIM>
        </Gene>
        <Gene Symbol="MXRA5" FullName="matrix remodeling associated 5" GeneID="25878" HGNC_ID="HGNC:7539" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xp22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="3308565" stop="3346652" display_start="3308565" display_stop="3346652" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="3226605" stop="3264683" display_start="3226605" display_stop="3264683" Strand="-" />
          </Location>
          <OMIM>300938</OMIM>
        </Gene>
        <Gene Symbol="PRKX" FullName="protein kinase cAMP-dependent X-linked catalytic subunit" GeneID="5613" HGNC_ID="HGNC:9441" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xp22.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="3604340" stop="3713649" display_start="3604340" display_stop="3713649" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="3522383" stop="3631674" display_start="3522383" display_stop="3631674" Strand="-" />
          </Location>
          <OMIM>300083</OMIM>
        </Gene>
      </GeneList>
      <Name>GRCh37/hg19 Xp22.33-22.32(chrX:60000-4857212)x1</Name>
      <VariantType>copy number loss</VariantType>
      <Location>
        <CytogeneticLocation>Xp22.33-22.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="60000" stop="4857212" display_start="60000" display_stop="4857212" variantLength="4797213" />
      </Location>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="GRCh37/hg19 Xp22.33-22.32(chrX:60000-4857212)x1 AND not provided" Accession="RCV001270673" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="CN517202">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-03-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-03-26" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-12-19" MostRecentSubmission="2023-03-04">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10713888</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11889216</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17091221</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21325865</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27604558</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301394</ID>
          <ID Source="BookShelf">NBK1215</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301713</ID>
          <ID Source="BookShelf">NBK1544</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Developmental Genetics Unit, King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="CN517202" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2865776" SubmissionDate="2020-12-18" DateLastUpdated="2023-03-04" DateCreated="2020-12-19">
        <ClinVarSubmissionID localKey="1735061" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001451404" DateUpdated="2023-03-04" DateCreated="2020-12-19" Type="SCV" Version="2" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-03-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10713888</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11889216</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17091221</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20301394</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20301713</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21325865</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27604558</ID>
          </Citation>
          <Comment>This CNV is a 4.8 Mb deletion of Xp22.33-p22.32 on chromosome X, (seq[GRCh37]del(X)(p22.33p22.32); chrX:g.60000_4857212del). The CNV constitutes a loss encompassing 52 genes and includes the entire SHOX and ARSL genes, associated with SHOX deficiency disorders and X-linked recessive chondrodysplasia punctata, respectively. Both conditions are related to skeletal phenotypes. SHOX deficiency disorders represent a spectrum ranging from a milder phenotype of short stature to the more severe conditions Leri-Weill dyschondrosteosis (LWD) and Langer mesomelicdysplasia (LMD). Common features include short stature, mesomelia, and Madelung deformity. An increase in severity with age has been noted and higher proportion of affected females have been reported (Binder and Rappold 2005). There is some evidence for beneficial outcomes with recombinant human growth hormone treatment and the Food and Drug Administration has approved use of recombinant human growth hormone for treating short stature in the pediatric population (Binder 2011). X-linked chondrodysplasia punctata 1 affects bone development and cartilage, and generally occurs in males. Common features include stippled epiphyses, brachytelephalangy, and nasomaxillary hypoplasia and some individuals may also have hearing loss and intellectual disability (Braverman et al. 2008). At least 30 unrelated cases with similar or smaller deletions that fall within the boundaries of the CNV have been described, presenting with SHOX-related LWD or LMD; derivative chromosomes were present in at least two cases (Schiller et al. 2000; Gatta et al. 2007; Benito-Sanz et al. 2017). Variable expressivity has been observed with similar CNVs showing phenotypes across the spectrum of the disorders. In addition, studies suggest that the size of the CNV may not correlate with severity of clinical presentation (Schiller et al. 2000; Benito-Sanz et al. 2017). Partial or full gene deletions were not reported in 110 healthy controls (Rappold et al. 2002; Gatta et al. 2007). Based on the collective evidence, this CNV is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL CNVClassificationCriteria Aug2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/wisyz6nm/icsl_cnvclassificationcriteria_aug2020.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Sequence alignment</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>copy number loss</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="X" start="60000" stop="4857212" variantLength="4797213" />
          </Location>
          <AttributeSet>
            <Attribute Type="AbsoluteCopyNumber">1</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8756374</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2865776" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="CN517202" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

